Sickle cell chronic pulmonary disease among Africans: the need for increased recognition and treatment

dc.contributor.authorFawibe, AE
dc.date.accessioned2023-07-13T11:41:51Z
dc.date.available2023-07-13T11:41:51Z
dc.date.issued2008
dc.description.abstractThe pulmonary complications of sickle cell disease (SCD) among adults are expected to increase since more of them are expected to survive into adulthood with improved healthcare delivery systems. Such complications, especially the chronic ones, which are usually collectively referred to as SCCLD (sickle cell chronic lung disease), are often under-appreciated by healthcare providers in sub-Saharan Africa. However, results of recent work in Nigeria show that SCCLD might not be as uncommon as previously thought. It is very important to detect SCCLD at an early stage, which is usually asymptomatic; the late stages are not usually responsive to conventional treatment. In Africa, outline spirometry can be used as a screening test for asymptomatic SCCLD in the follow-up of SCD. Patients with asymptomatic SCCLD should be offered measures that can prevent further deterioration of their condition, while those with more advanced symptomatic disease are treated symptomatically.en_US
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/20.500.12484/11483
dc.language.isoenen_US
dc.publisherPan African Thoracic Societyen_US
dc.titleSickle cell chronic pulmonary disease among Africans: the need for increased recognition and treatmenten_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Sickle Cell Chronic Lung Disease need 4 increased recognition and Treatment.pdf
Size:
179.04 KB
Format:
Adobe Portable Document Format
Description:
main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections